Axsome Therapeutics, Inc. (AXSM)
168.50
-3.28
(-1.91%)
USD |
NASDAQ |
Apr 02, 16:00
168.52
+0.02
(+0.01%)
After-Hours: 20:00
Axsome Therapeutics EPS Diluted (Quarterly) : -0.5641 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Madrigal Pharmaceuticals, Inc. | -2.566 |
| Amicus Therapeutics, Inc. | 0.0054 |
| Insmed, Inc. | -1.538 |
| MannKind Corp. | -0.0519 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -28.56M |
| Revenue (Quarterly) | 196.00M |
| Total Expenses (Quarterly) | 224.56M |
| Enterprise Value | 8.515B |
| Gross Profit Margin (Quarterly) | 92.55% |
| Profit Margin (Quarterly) | -14.57% |
| Earnings Yield | -2.23% |
| Normalized Earnings Yield | -2.166 |